Literature DB >> 12172216

The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors.

Birgitte B Rasmussen1, Thomas H Brix, Kirsten O Kyvik, Kim Brøsen.   

Abstract

This study investigated the role of genetic factors (CYP1A2) in caffeine metabolism. The CYP1A2 activity was determined in 378 Danish twins following oral intake of a single dose of 200 mg caffeine and subsequent determination of the caffeine ratio (AFMU+1MU+1MX)/17DMU in a 6-h urine sample. The mean (+/- SD) caffeine ratio was 5.9 +/- 3.4. The caffeine ratio was statistically significantly higher in men compared to women, in smoking men and women compared to non-smoking persons of the same gender and in women not taking oral contraceptives compared with women on oral contraceptives. Thus, we confirmed that CYP1A2 is more active in men than in women, that it is induced by smoking and inhibited by oral contraceptives. In the subsequent analysis of heritability, we included 49 monozygotic twin pairs and 34 same gender dizygotic twin pairs concordant for non-smoking and non-use of oral contraceptives. The intraclass correlation coefficient was 0.798 (95% confidence interval, 0.696-0.900) and 0.394 (95% confidence interval, 0.109-0.680) in the monozygotic and dizygotic twins, respectively. The correlation was statistically significantly higher (P = 0.0015) in the former compared with the latter. A biometrical model for the caffeine ratio including only additive genetic factors and unique environmental factors was the overall best fitting model. Estimates based on this model gave a heritability estimate of 0.725 (95% confidence interval 0.577-0.822). Unique environmental effects seem to account for the remainder 0.275 (95% confidence interval, 0.178-0.423). Our study shows that the CYP1A2 activity is mainly governed by genetic factors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12172216     DOI: 10.1097/00008571-200208000-00008

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  54 in total

1.  Systemic uptake of miconazole during vaginal suppository use and effect on CYP1A2 and CYP3A4 associated enzyme activities in women.

Authors:  Mia Birkhøj Kjærstad; Flemming Nielsen; Lene Nøhr-Jensen; Stine Zwisler; Kim Brøsen; Helle Raun Andersen
Journal:  Eur J Clin Pharmacol       Date:  2010-10-06       Impact factor: 2.953

Review 2.  Genetics of caffeine consumption and responses to caffeine.

Authors:  Amy Yang; Abraham A Palmer; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2010-06-09       Impact factor: 4.530

3.  Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity.

Authors:  Sebastian Härtter; Anna Nordmark; Dirk-Matthias Rose; Leif Bertilsson; Gunnel Tybring; Kari Laine
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

4.  Caffeine, selected metabolic gene variants, and risk for neural tube defects.

Authors:  Rebecca J Schmidt; Paul A Romitti; Trudy L Burns; Jeffrey C Murray; Marilyn L Browne; Charlotte M Druschel; Richard S Olney
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-07

5.  Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans.

Authors:  Roza Ghotbi; Magnus Christensen; Hyung-Keun Roh; Magnus Ingelman-Sundberg; Eleni Aklillu; Leif Bertilsson
Journal:  Eur J Clin Pharmacol       Date:  2007-03-17       Impact factor: 2.953

6.  Current status on genome-metabolome-wide associations: an opportunity in nutrition research.

Authors:  Ivan Montoliu; Ulrich Genick; Mirko Ledda; Sebastiano Collino; François-Pierre Martin; Johannes le Coutre; Serge Rezzi
Journal:  Genes Nutr       Date:  2012-10-16       Impact factor: 5.523

Review 7.  Cigarette smoking and clopidogrel interaction.

Authors:  Kristopher J Swiger; Omair Yousuf; Kevin P Bliden; Udaya S Tantry; Paul A Gurbel
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

8.  Gender Differences in Any-Source Caffeine and Energy Drink Use and Associated Adverse Health Behaviors.

Authors:  Pamela Dillon; Sydney Kelpin; Kenneth Kendler; Leroy Thacker; Danielle Dick; Dace Svikis
Journal:  J Caffeine Adenosine Res       Date:  2019-03-14

9.  Pharmacokinetics of Rasagiline in Healthy Adult Chinese Volunteers with Various Genotypes: A Single-Center, Open-Label, Multiple-Dose Study.

Authors:  Xia Chen; Qian Zhao; Ji Jiang; Jian Liu; Pei Hu
Journal:  Clin Drug Investig       Date:  2016-05       Impact factor: 2.859

10.  Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidine.

Authors:  Janne T Backman; Marika T Schröder; Pertti J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  2007-10-23       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.